Barr, Teva to Launch Generic Allegra Versions
- Share via
From Associated Press
Barr Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. said they would cooperate in launching generic versions of Sanofi-Aventis’ Allegra allergy drug.
Barr of Pomona, N.Y., received final approval last week for the generic drug from the Food and Drug Administration.
Allegra sales were worth $1.4 billion for the 12 months ended in June, according to research firm IMS Health.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
